Bone fractures after cardiac transplantation

Area of Science:

• Orthopedics
• Transplantation Medicine
• Pharmacology

Background:

• Bone loss and fractures are significant complications following heart transplantation, primarily occurring within the first year.
• Steroids and cyclosporine negatively impact bone metabolism, necessitating antiresorptive therapies.

Purpose of the Study:

• To determine the incidence of bone fractures in heart transplant recipients.
• To analyze the influence of pre-existing comorbidities, immunosuppressive regimens, and osteoprotective treatments on fracture occurrence.

Main Methods:

• A cohort of 443 heart transplant recipients was retrospectively analyzed from 1993 to 2005.
• Data collected included fracture occurrence, immunosuppressive therapy details, clinical conditions, and antiresorptive treatment administration.

Main Results:

• A total of 41 fractures (7.6%) were observed in 34 patients. Lumbar spine fractures were most common.
• Postmenopausal women (20.6%) and overweight patients (61.8% incidence) showed higher fracture rates.
• Initial immunosuppression with tacrolimus was associated with a significantly lower fracture incidence (P = .01).

Conclusions:

• The study indicates a low overall frequency of bone fractures after heart transplantation.
• Risk factors for fractures include being postmenopausal or overweight.
• Utilizing tacrolimus as an initial immunosuppressive agent may reduce fracture rates in this patient population.